Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 February 2018 Photo Facebook
Louzanne and Marné included in national student cross country teams
Athlete Louzanne Coetzee, and her guide, Xavier Adams

Two Kovsie athletes, including the blind athlete and world record holder, Louzanne Coetzee, have been included in the national student cross country team.

Coetzee and Marné Mentz will compete at the World Student Cross Country championship on 7 April in St Gallen in Switzerland.

They qualified for the team after good performances at the Athletics South Africa’s cross country trials held at the University of the Free State (UFS) on 20 January. The distance was over 10km.

What makes Coetzee’s inclusion even more remarkable is the fact that she will be competing against able-bodied runners. The world record holder in the 5 000m in her disability category (T-11) and her new guide, Xavier Adams, finished first among the female students in a time of 39:32, which is her personal best. Mentz ended in second place for students in 39:44. They will make up two of the six spots in the women’s team in Switzerland.

First for Coetzee

It is the first time that Coetzee was chosen for an able-bodied national team. She is doing a master’s degree in Reconciliation and Social Cohesion this year and Mentz is in her final year of a BEd Intermediate Phase.

Tshepang Sello, another Kovsie and an Olympic athlete from Lesotho, took first position for students in 38:04 but did not qualify for the South African team because of her Lesotho citizenship.

Kesa Molotsane (35:29) was the overall winner. Although Molotsane is still doing her honours this year, she ran in the open division as she no longer qualifies as a student because she is over the age of 25, according to University Sport South Africa regulations.

Molotsane ,26, is the national cross country champion of 2016 and obtained second spot last year.

News Archive

UFS cardiac team does pioneering work
2017-10-29

Description: ' 000 Cardiac Pioneers Tags: Cardiac Pioneers 

“With the use of endomyocardial biopsies, the team hopes to treat viruses unique
to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

Photo: iStock

Members of the University of the Free State’s (UFS) Cardiac team had various achievements at national and international level this year. The Robert WM Frater Cardiovascular Research Centre in the Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.

With an Afrocentric research focus, Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition, and 50% of patients who have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made, where virus infections of the heart muscle, or myocarditis, have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

According to Prof Mokoali Makotoko, Head of the Department of Cardiology, more than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies, the team hopes to treat viruses unique to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

The study is a project that flows from Prof Makotoko’s PhD. The project is being run with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

 "More than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy."

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept